Richard  Bogan  to  Male
                            
                            
                                This is a "connection" page, showing publications  Richard  Bogan  has written about  Male.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.540
         
        
        
     
 
    
        
        - 
            Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers. Sleep Med. 2022 Dec; 100:442-447.
            
            
                Score: 0.044
             
- 
            Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial. Ann Am Thorac Soc. 2020 08; 17(8):998-1007.
            
            
                Score: 0.038
             
- 
            Demographic and nap-related variance of the MSLT: results from 2,498 suspected hypersomnia patients: Clinical MSLT variance. Sleep Med. 2019 03; 55:115-123.
            
            
                Score: 0.034
             
- 
            Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations. Postgrad Med. 2017 Sep; 129(7):667-675.
            
            
                Score: 0.031
             
- 
            Utility of home sleep apnea testing in high-risk veterans. Sleep Breath. 2017 Sep; 21(3):647-655.
            
            
                Score: 0.030
             
- 
            Underutilization of the MSLT in sleepy patients with a short onset REM period (SOREMP) in the sleep clinic. Sleep Med. 2017 Apr; 32:150-156.
            
            
                Score: 0.030
             
- 
            Prevalence and Clinical Correlates of a Short Onset REM Period (SOREMP) during Routine PSG. Sleep. 2015 Oct 01; 38(10):1575-81.
            
            
                Score: 0.027
             
- 
            Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy. Sleep Med. 2015 Sep; 16(9):1102-8.
            
            
                Score: 0.027
             
- 
            Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy. J Clin Sleep Med. 2015 Apr 15; 11(4):427-32.
            
            
                Score: 0.026
             
- 
            Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil. Ann Med. 2015 May; 47(3):269-77.
            
            
                Score: 0.026
             
- 
            Who is getting tested for obstructive sleep apnea using a portable recording system? Test results from 193,221 patients. J Clin Sleep Med. 2014 Nov 15; 10(11):1193-8.
            
            
                Score: 0.026
             
- 
            Restless legs syndrome: a review of diagnosis and management in primary care. Postgrad Med. 2013 May; 125(3):99-111.
            
            
                Score: 0.023
             
- 
            Sleep disordered breathing analysis in a general population using standard pulse oximeter signals. Sleep Breath. 2013 Sep; 17(3):1109-15.
            
            
                Score: 0.023
             
- 
            Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study. Mayo Clin Proc. 2010 Jun; 85(6):512-21.
            
            
                Score: 0.019
             
- 
            Lack of impairment in glucose tolerance: support for further investigation of sleep restriction in older long sleepers. J Sleep Res. 2010 Mar; 19(1 Pt 1):116-7.
            
            
                Score: 0.018
             
- 
            Weight loss in narcolepsy patients treated with sodium oxybate. Sleep Med. 2009 Jun; 10(6):661-3.
            
            
                Score: 0.017
             
- 
            Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006 Jan; 81(1):17-27.
            
            
                Score: 0.014
             
- 
            Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. J Neuropsychiatry Clin Neurosci. 2005; 17(3):405-12.
            
            
                Score: 0.013
             
- 
            Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS. Sleep Med. 2019 02; 54:94-100.
            
            
                Score: 0.008
             
- 
            Longitudinal study of narcolepsy symptoms in first, second, and third-degree relatives of simplex and multiplex narcolepsy families. Sleep Med. 2019 01; 53:88-93.
            
            
                Score: 0.008
             
- 
            Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes. Sleep Med. 2017 Jul; 35:12-16.
            
            
                Score: 0.008
             
- 
            Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy. Sleep Med. 2016 08; 24:57-62.
            
            
                Score: 0.007
             
- 
            The National Veteran Sleep Disorder Study: Descriptive Epidemiology and Secular Trends, 2000-2010. Sleep. 2016 Jul 01; 39(7):1399-410.
            
            
                Score: 0.007
             
- 
            A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea. Sleep Med. 2013 Sep; 14(9):830-7.
            
            
                Score: 0.006
             
- 
            Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome. Mov Disord. 2011 Sep; 26(11):2065-72.
            
            
                Score: 0.005
             
- 
            Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord. 2010 Aug 15; 25(11):1675-83.
            
            
                Score: 0.005
             
- 
            A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc. 2010 Jul; 85(7):630-8.
            
            
                Score: 0.005
             
- 
            Tolerance of chronic 90-minute time-in-bed restriction in older long sleepers. Sleep. 2009 Nov; 32(11):1467-79.
            
            
                Score: 0.005
             
- 
            No effect of 8-week time in bed restriction on glucose tolerance in older long sleepers. J Sleep Res. 2008 Dec; 17(4):412-9.
            
            
                Score: 0.004
             
- 
            Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep. 2004 Aug 01; 27(5):907-14.
            
            
                Score: 0.003
             
- 
            Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy. Clin Neuropharmacol. 2003 Sep-Oct; 26(5):252-7.
            
            
                Score: 0.003